Antibiotics

Antimicrobial Review: Drug-resistant infections are the silent pandemic

Read more

More advanced planning needed for antimicrobials

Read more

New antibiotics pass regulatory hurdles

Read more

Destiny Pharma advances strategy against bacteria

Read more

Insect-derived peptides - next generation antibiotics?

Read more

Time for action against antimicrobial resistance

Read more

Exploring new business models for antibiotics

Read more

Building the antibiotic pipeline

Read more

Meeting Report: Funding rises for early assets

Read more

Sourcing antibiotics from the nematode worm

Read more